 |
市場調查報告書
商品編碼
1863941
外泌體研究市場按產品類型、疾病適應症、工作流程、研發階段、最終用戶和地區分類Exosome Research Market, By Product Type, By Disease Indication, By Workflow, By Development Stage, By End User, By Geography |
||||||
預計到 2025 年，外泌體研究市場價值將達到 2.415 億美元，預計到 2032 年將達到 7.512 億美元，2025 年至 2032 年的複合年成長率為 17.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2024 | 2025年市場規模： | 2.415億美元 |
| 性能數據： | 2020年至2024年 | 預測期： | 2025年至2032年 |
| 預測期（2025-2032年）複合年成長率： | 17.60% | 2032 年價值預測： | 7.512億美元 |
全球外泌體研究市場是生物技術和生命科學產業中一個快速發展的細分市場，專注於研究和應用外泌體，外泌體是一種奈米級細胞外囊泡，在細胞間通訊中起著關鍵作用。
這些膜包裹的囊泡，直徑通常為30-150奈米，由多種細胞類型分泌，並攜帶多種分子物質，包括蛋白質、脂質和核酸。外泌體已成為疾病診斷、治療標靶和藥物傳遞載體的重要生物標記物，尤其是在腫瘤學、神經病學和再生醫學領域。
該市場涵蓋了外泌體研究所需的各種研究工具、分離純化技術、表徵設備和分析服務。對外泌體生物學特性及其在精準醫療領域應用潛力的深入了解，吸引了來自製藥、學術和生物技術公司的巨額投資。分離技術、分析方法和標準化通訊協定的顯著技術進步正在推動市場擴張。
關鍵應用領域涵蓋生物標記發現、治療方法開發和診斷應用，特別著重於液態生物檢體技術和個人化醫療方法，將外泌體研究市場定位為下一代生物醫學研究和臨床應用的基礎。
市場動態
全球外泌體研究市場受多種強勁因素驅動，這些因素支撐著其巨大的成長潛力和在研究及臨床應用中的廣泛應用。其中一個關鍵促進因素是全球癌症和神經系統疾病的日益普及。外泌體憑藉其疾病特異性分子特徵和微創檢測能力，成為極具潛力的候選靶點，從而刺激了對新型診斷生物標記和治療方法的需求。液態生物檢體技術的日益普及也是一個重要促進因素，因為與傳統的組織切片檢查相比，外泌體具有諸多優勢，只需簡單的抽血即可實現疾病的即時監測和治療效果評估。
此外，製藥公司和學術機構對研發的大量投入，以及政府對外泌體研究舉措的資助不斷增加，都在推動市場成長。然而，也存在一些顯著的局限性，例如缺乏標準化的分離和鑑定通訊協定，導致研究結果存在差異，並阻礙了臨床應用的監管核准。
外泌體異質性、低產量分離方法以及複雜的分析技術等技術挑戰也阻礙了市場擴張。此外，專用設備和試劑的高成本，以及終端用戶對外泌體應用認知度較低，也限制了市場滲透。儘管存在這些挑戰，外泌體在藥物遞送系統中仍具有巨大的應用潛力，因為與合成載體相比，它們天然的生物相容性和標靶化能力使其具有更優異的治療效果。
人們對個人化醫療和精準診斷的興趣日益濃厚，為基於外泌體的生物標記的發展創造了巨大的機遇，尤其是在疾病早期檢測和預後預測方面。同時，亞太和拉丁美洲等新興市場，在醫療保健投資不斷增加和研究基礎設施不斷發展的推動下，為市場擴張提供了尚未開發的潛力。
本次調查的主要特點
- 本報告對全球外泌體研究市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）內的市場規模和複合年成長率（%）。
- 它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 該研究根據以下參數對全球外泌體研究市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 本報告的目標受眾是全球外泌體研究市場的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過各種用於分析全球外泌體研究市場的策略矩陣輕鬆做出決策。
目錄
第1章：調查目標和前提條件
- 調查目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進要素
- 抑制因素
- 機會
- 影響分析
- 重大進展
- 監管情景
- 產品發布/核准
- PEST分析
- 波特五力分析
- 併購情景
- 產業趨勢
4. 全球外泌體研究市場（依產品類型分類），2020-2032 年
- 耗材（試劑盒、試劑、層析管、磁珠、濾芯）
- 設備（例如，NTA儀器、微流體裝置、蛋白質印跡儀、ELISA儀器）
- 軟體和服務
5. 全球外泌體研究市場（依應用領域分類），2020-2032年
- 診斷（例如，癌症生物標記檢測、神經系統疾病診斷、液態生物檢體）
- 治療藥物（例如，藥物傳遞系統、再生醫學、疫苗研發）
- 研究與發展（基礎研究、藥物發現、疾病機制研究）
6. 全球外泌體研究市場（依疾病適應症分類），2020-2032 年
- 腫瘤學
- 神經病學/神經退化
- 心血管系統
- 感染疾病
- 代謝/內分泌
- 自體免疫/炎症
- 生殖/產前
- 其他（例如，皮膚科、眼科）
7. 全球外泌體研究市場（依工作流程分類），2020-2032 年
- 分離方法
- 超速離心
- 降水法
- 親和性和捕獲
- 基於尺寸的分離
- 微流體技術
- 下游分析
- 表徵（粒徑、濃度、表面標誌物）
- 利用流式細胞技術進行細胞表面標誌物分析
- 利用印跡法和ELISA法進行蛋白質分析
- 利用NGS和PCR進行RNA分析
- 利用質譜法進行蛋白質體分析
- 其他
8. 全球外泌體研究市場（依發展階段分類），2020-2032 年
- 發現
- 臨床前
- 臨床 I
- 臨床二期
- 臨床三期
9. 全球外泌體研究市場（依最終用戶分類），2020-2032 年
- 醫院和臨床實驗室
- 製藥和生物技術公司
- 醫院和診斷中心
- 政府/非營利組織
- 學術研究機構
- 其他（CRO/CMO）
第10章：2020-2032年全球外泌體研究市場（按地區分類）價值
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中非
第11章 競爭格局
- Thermo Fisher Scientific
- Illumina Inc
- Miltenyi Biotec
- QIAGEN
- Exosome Diagnostics
- Lonza Group
- Sysmex Corporation
- StellaLife Inc
- Cell Guidance Systems
- Bio-Techne Corporation
- Nanosomix
- Roche
- Cytiva
- Nanovision Biosciences
- Luminex Corporation
第12章 分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第13章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Exosome Research Market is estimated to be valued at USD 241.5 Mn in 2025 and is expected to reach USD 751.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 17.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 241.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 17.60% | 2032 Value Projection: | USD 751.2 Mn |
The global exosome research market represents a rapidly evolving sector within the biotechnology and life sciences industry, focusing on the study and application of exosomes - nanoscale extracellular vesicles that play crucial roles in intercellular communication.
These membrane-bound vesicles, typically ranging from 30-150 nanometers in diameter, are secreted by various cell types and contain diverse molecular cargo including proteins, lipids, and nucleic acids. Exosomes have emerged as significant biomarkers for disease diagnosis, therapeutic targets, and drug delivery vehicles, particularly in oncology, neurology, and regenerative medicine applications.
The market encompasses research tools, isolation and purification technologies, characterization instruments, and analytical services essential for exosome studies. Growing understanding of exosome biology and their potential in precision medicine has attracted substantial investment from pharmaceutical companies, academic institutions, and biotechnology firms. The field has witnessed remarkable technological advancements in isolation techniques, analytical methodologies, and standardization protocols, driving market expansion.
Key applications span across biomarker discovery, therapeutic development, and diagnostic applications, with particular emphasis on liquid biopsy technologies and personalized medicine approaches, positioning the exosome research market as a cornerstone of next-generation biomedical research and clinical applications.
Market Dynamics
The global exosome research market is propelled by several compelling drivers that underscore its significant growth potential and widespread adoption across research and clinical applications. The primary driver stems from the increasing prevalence of cancer and neurological disorders globally, which has intensified the demand for novel diagnostic biomarkers and therapeutic approaches, positioning exosomes as promising candidates due to their disease-specific molecular signatures and minimal invasive detection capabilities. The rising adoption of liquid biopsy technologies represents another crucial driver, as exosomes offer advantages over traditional tissue biopsies by providing real-time disease monitoring and treatment response assessment through simple blood draws.
Additionally, substantial investments in research and development by pharmaceutical companies and academic institutions, coupled with growing government funding for exosome research initiatives, have accelerated market growth. However, the market faces notable restraints including the lack of standardized isolation and characterization protocols, which creates variability in research outcomes and hinders regulatory approvals for clinical applications.
Technical challenges related to exosome heterogeneity, low yield isolation methods, and the complexity of analytical techniques pose additional barriers to market expansion. Furthermore, high costs associated with specialized equipment and reagents, along with limited awareness among end users about exosome applications, restrict market penetration. Despite these challenges, significant opportunities emerge from the expanding applications of exosomes in drug delivery systems, where their natural biocompatibility and targeting capabilities offer superior therapeutic outcomes compared to synthetic carriers.
The growing focus on personalized medicine and precision diagnostics creates substantial opportunities for exosome-based biomarker development, particularly in early disease detection and prognosis prediction, while emerging markets in Asia Pacific and Latin America present untapped potential for market expansion through increasing healthcare investments and research infrastructure development.
Key Features of the Study
- This report provides in-depth analysis of the global exosome research market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global exosome research market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Illumina Inc, Miltenyi Biotec, QIAGEN, Exosome Diagnostics, Lonza Group, Sysmex Corporation, StellaLife Inc, Cell Guidance Systems, Bio-Techne Corporation, Nanosomix, Roche, Cytiva, Nanovision Biosciences, and Luminex Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global exosome research market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosome research market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Consumables (kits, reagents, columns, beads, cartridges)
- Instruments (e.g., NTA devices, microfluidic devices, Western blot, ELISA instruments)
- Software and Services
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Diagnostics (e.g., cancer biomarker detection, neurological disease diagnostics, liquid biopsy)
- Therapeutics (e.g., drug delivery systems, regenerative medicine, vaccine development)
- Research and Development (basic research, drug discovery, disease mechanism studies)
- Disease Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Neurology/neurodegeneration
- Cardiovascular
- Infectious diseases
- Metabolic/endocrine
- Autoimmune/inflammation
- Reproductive/prenatal
- Others (e.g., dermatology, ophthalmology)
- Workflow Insights (Revenue, USD Mn, 2020 - 2032)
- Isolation Methods
- Ultracentrifugation
- Precipitation
- Immunoaffinity Capture
- Size-Based Isolation
- Microfluidic Techniques
- Downstream Analysis
- Characterization (Particle Size, Concentration, Surface Markers)
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
- Development Stage Insights (Revenue, USD Mn, 2020 - 2032)
- Discovery
- Preclinical
- Clinical I
- Clinical II
- Clinical III
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and clinical laboratories
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostics Centers
- Government/Non-profit Centers
- Academic and research institutes
- Others (CROs/CMOs)
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Illumina Inc
- Miltenyi Biotec
- QIAGEN
- Exosome Diagnostics
- Lonza Group
- Sysmex Corporation
- StellaLife Inc
- Cell Guidance Systems
- Bio-Techne Corporation
- Nanosomix
- Roche
- Cytiva
- Nanovision Biosciences
- Luminex Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Exosome Research Market, By Product Type
- Global Exosome Research Market, By Application
- Global Exosome Research Market, By Disease Indication
- Global Exosome Research Market, By Workflow
- Global Exosome Research Market, By Development Stage
- Global Exosome Research Market, By End User
- Global Exosome Research Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Exosome Research Market, By Product Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Consumables (kits, reagents, columns, beads, cartridges)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Instruments (e.g., NTA devices, microfluidic devices, Western blot, ELISA instruments)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Exosome Research Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diagnostics (e.g., cancer biomarker detection, neurological disease diagnostics, liquid biopsy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Therapeutics (e.g., drug delivery systems, regenerative medicine, vaccine development)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research and Development (basic research, drug discovery, disease mechanism studies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Exosome Research Market, By Disease Indication, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Neurology/neurodegeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Metabolic/endocrine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Autoimmune/inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Reproductive/prenatal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (e.g., dermatology, ophthalmology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Exosome Research Market, By Workflow, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Isolation Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ultracentrifugation
- Precipitation
- Immunoaffinity Capture
- Size-Based Isolation
- Microfluidic Techniques
- Downstream Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Characterization (Particle Size, Concentration, Surface Markers)
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
8. Global Exosome Research Market, By Development Stage, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Preclinical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Exosome Research Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and clinical laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hospitals and Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Government/Non-profit Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Exosome Research Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exosome Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- StellaLife Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Guidance Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanosomix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cytiva
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanovision Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us
